Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma

被引:2
|
作者
Rameh, V. [1 ]
Vajapeyam, S. [1 ]
Ziaei, A. [1 ]
Kao, P. [2 ]
London, W. B. [2 ]
Baker, S. J. [3 ]
Chiang, J. [4 ,5 ]
Lucas, J.
Tinkle, C. L. [5 ]
Wright, K. D. [2 ]
Poussaint, T. Y. [1 ,6 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[3] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN USA
[4] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
[5] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN USA
[6] Boston Childrens Hosp, Dept Radiol, 300 Longwood Ave, Boston, MA 02115 USA
关键词
DIFFUSE MIDLINE GLIOMAS; CENTRAL-NERVOUS-SYSTEM; APPARENT DIFFUSION; TUMORS; SURVIVAL; FEATURES; CLASSIFICATION; MUTATIONS; SUBGROUPS; BIOPSY;
D O I
10.3174/ajnr.A7910
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Molecular profiling is a crucial feature in the "integrated diagnosis" of CNS tumors. We aimed to determine whether radiomics could distinguish molecular types of pontine pediatric high-grade gliomas that have similar/overlapping phenotypes on conventional anatomic MR images.MATERIALS AND METHODS: Baseline MR images from children with pontine pediatric high-grade gliomas were analyzed. Retrospective imaging studies included standard precontrast and postcontrast sequences and DTI. Imaging analyses included median, mean, mode, skewness, and kurtosis of the ADC histogram of the tumor volume based on T2 FLAIR and enhancement at baseline. Histone H3 mutations were identified through immunohistochemistry and/or Sanger or next-generation DNA sequencing. The log-rank test identified imaging factors prognostic of survival from the time of diagnosis. Wilcoxon rank-sum and Fisher exact tests compared imaging predictors among groups.RESULTS: Eighty-three patients had pretreatment MR imaging and evaluable tissue sampling. The median age was 6 years (range, 0.7-17 years); 50 tumors had a K27M mutation in H3-3A, and 11, in H3C2/3. Seven tumors had histone H3 K27 alteration, but the specific gene was unknown. Fifteen were H3 wild-type. Overall survival was significantly higher in H3C2/3-compared with H3-3A -mutant tumors (P = .003) and in wild-type tumors compared with any histone mutation (P = .001). Lower overall survival was observed in patients with enhancing tumors (P = .02) compared with those without enhancement. H3C2/3-mutant tumors showed higher mean, median, and mode ADC_total values (P<.001) and ADC_enhancement (P<.004), with lower ADC_total skewness and kurtosis (P<.003) relative to H3-3A-mutant tumors. CONCLUSIONS: ADC histogram parameters are correlated with histone H3 mutation status in pontine pediatric high-grade glioma.
引用
收藏
页码:833 / 840
页数:8
相关论文
共 50 条
  • [41] Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
    Gutierrez, Daniel Rodriguez
    Jones, Chris
    Varlet, Pascale
    Mackay, Alan
    Warren, Daniel
    Warmuth-Metz, Monika
    Aliaga, Esther Sanchez
    Calmon, Raphael
    Hargrave, Darren R.
    Canete, Adela
    Massimino, Maura
    Azizi, Amedeo A.
    Le Deley, Marie-Cecile
    Saran, Frank
    Rousseau, Raphael F.
    Zahlmann, Gudrun
    Garcia, Josep
    Vassal, Gilles
    Grill, Jacques
    Morgan, Paul S.
    Jaspan, Tim
    CLINICAL CANCER RESEARCH, 2020, 26 (08) : 1856 - 1865
  • [42] Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma
    Minasi, Simone
    Baldi, Caterina
    Gianno, Francesca
    Antonelli, Manila
    Buccoliero, Anna Maria
    Pietsch, Torsten
    Massimino, Maura
    Buttarelli, Francesca Romana
    CHILDS NERVOUS SYSTEM, 2021, 37 (03) : 809 - 818
  • [43] Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients
    Karremann, Michael
    Hoffmann, Marion
    Benesch, Martin
    Kwiecien, Robert
    von Bueren, Andre O.
    Kramm, Christof M.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (07) : 467 - 473
  • [44] Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
    Ocasio, Jennifer K.
    Budd, Kaitlin M.
    Roach, Jordan T.
    Andrews, Jared M.
    Baker, Suzanne J.
    CANCER AND METASTASIS REVIEWS, 2023, 42 (02) : 367 - 388
  • [45] The Subventricular Zone, a Hideout for Adult and Pediatric High-Grade Glioma Stem Cells
    Lombard, Arnaud
    Digregorio, Marina
    Delcamp, Clement
    Rogister, Bernard
    Piette, Caroline
    Coppieters, Natacha
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [46] Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma
    Liu, Zhenyin
    Zhang, Jing
    BMC NEUROLOGY, 2020, 20 (01)
  • [47] Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas
    Barrow, Jennifer
    Adamowicz-Brice, Martyna
    Cartmill, Maria
    MacArthur, Donald
    Lowe, James
    Robson, Keith
    Brundler, Marie-Anne
    Walker, David A.
    Coyle, Beth
    Grundy, Richard
    NEURO-ONCOLOGY, 2011, 13 (02) : 212 - 222
  • [48] Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma
    Fan, Ziwen
    Liu, Yukun
    Li, Shaowu
    Liu, Xing
    Jiang, Tao
    Wang, Yinyan
    Wang, Lei
    AGING-US, 2020, 12 (09): : 7908 - 7926
  • [49] Diffusional Kurtosis Imaging for Differentiating between High-Grade Glioma and Primary Central Nervous System Lymphoma
    Pang, Haopeng
    Ren, Yan
    Dang, Xuefei
    Feng, Xiaoyuan
    Yao, Zhenwei
    Wu, Jingsong
    Yao, Chengjun
    Di, Ning
    Ghinda, Diana Cristina
    Zhang, Yong
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 44 (01) : 30 - 40
  • [50] Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma
    Schreck, Karisa C.
    Strowd, Roy E.
    Nabors, Louis B.
    Ellingson, Benjamin M.
    Chang, Michael
    Tan, Sze K.
    Abdullaev, Zied
    Turakulov, Rust
    Aldape, Kenneth
    Danda, Neeraja
    Desideri, Serena
    Fisher, Joy
    Iacoboni, Michaella
    Surakus, Trisha
    Rudek, Michelle A.
    Bettegowda, Chetan
    Grossman, Stuart A.
    Ye, Xiaobu
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2048 - 2056